ALKS: Alkermes plc
Performance
ALKS +40.38%
Watchlist
Select an item
Summary
ALKS at a glance
ALKS returned +40.38% over the past year and +9.09% a year over five years. Its worst drop in that year was -29.23%, smaller than 59% of stocks on Redstone, and its Sharpe ratio of 0.95 beats 73% of stocks on Redstone. It pays no dividends.
Current Drawdown
-16.39%
Rolling Volatility
29.67%
Actions
Metrics
Risk Indicators
Alpha30.80%
Beta0.77x
Sharpe0.95
Sortino1.56
Omega1.19
Calmar1.38
Martin2.90
Profile
About ALKS
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $7.8B
- Listed
- Jul 1991
- Employees
- 2,050
- Headquarters
- Dublin 4, L2
- Website
- alkermes.com
Comparisons